Dashboard Tools Market News Investing Ideas Pricing
Search 100,000+ stocks...
Sign Up
Log in
E-Therapeutics PLC banner

E-Therapeutics PLC
LSE:ETX

Watchlist Manager
E-Therapeutics PLC Logo
E-Therapeutics PLC
LSE:ETX
Watchlist
Price: 9 GBX -6.74% Market Closed
Market Cap: £52.6m
Write Note Create Alert Ask AI
Financials Section:
Income Statement Balance Sheet Cash Flow Statement

Cash Flow Statement

Operating Cash Flow
+
3Y
-295%
5Y
-82%
10Y
-93%
Investing Cash Flow
+
3Y
-
5Y
+118%
10Y
+590%
Financing Cash Flow
+
3Y
-
5Y
+108 617%
10Y
+65 130%

Cash Flow Statement
E-Therapeutics PLC

Rotate your device to view
Cash Flow Statement
Currency: GBP
Jul-2008 Jan-2009 Jul-2009 Jan-2010 Jul-2010 Jan-2011 Jul-2011 Jan-2012 Jul-2012 Jan-2013 Jul-2013 Jan-2014 Jul-2014 Jan-2015 Jul-2015 Jan-2016 Jul-2016 Jan-2017 Jul-2017 Jan-2018 Jul-2018 Jan-2019 Jul-2019 Jan-2020 Jul-2020 Jan-2021 Jul-2021 Jan-2022 Jul-2022 Jan-2023
Operating Cash Flow
Net Income
(2)
(2)
(2)
(2)
(2)
(2)
(3)
(3)
(4)
(4)
(5)
(5)
(7)
(8)
(8)
(9)
(12)
(13)
(8)
(5)
(5)
(4)
(3)
(2)
(3)
(4)
(4)
(8)
(9)
(8)
Depreciation & Amortization
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2
3
1
0
0
0
0
0
0
0
0
0
0
0
Other Non-Cash Items
0
(0)
(0)
(0)
(0)
(0)
(0)
(1)
(1)
(1)
(1)
(2)
(2)
(2)
(2)
(3)
(3)
(3)
(2)
(1)
(1)
(1)
(1)
(1)
(0)
(0)
(1)
(1)
(1)
(2)
Cash Taxes Paid
0
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(1)
(1)
(1)
(1)
(1)
(3)
(2)
(3)
(3)
(3)
(3)
(1)
(1)
(1)
(1)
(1)
(1)
(0)
(1)
(1)
(1)
Cash Interest Paid
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Change in Working Capital
(1)
0
1
0
0
0
0
1
1
1
0
1
(0)
0
4
2
4
4
2
2
1
1
1
1
0
1
0
1
0
2
Cash from Operating Activities
(3)
N/A
(2)
+40%
(2)
-10%
(2)
+2%
(2)
-2%
(2)
-12%
(3)
-42%
(3)
-19%
(4)
-11%
(4)
-16%
(5)
-29%
(6)
-7%
(9)
-56%
(10)
-10%
(7)
+30%
(9)
-32%
(9)
-1%
(9)
-2%
(7)
+24%
(4)
+39%
(5)
-9%
(4)
+23%
(2)
+34%
(2)
+17%
(3)
-61%
(3)
-3%
(5)
-34%
(8)
-73%
(9)
-21%
(8)
+15%
Investing Cash Flow
Capital Expenditures
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(1)
(1)
(0)
Other Items
0
0
0
(0)
(0)
0
(6)
(8)
0
2
(35)
(30)
14
5
1
14
17
8
5
7
3
3
2
0
0
(5)
(5)
(9)
6
16
Cash from Investing Activities
0
N/A
(0)
N/A
(0)
-133%
(0)
-200%
(0)
-24%
(0)
+54%
(6)
-4 958%
(8)
-30%
(0)
+97%
2
N/A
(35)
N/A
(31)
+12%
14
N/A
5
-65%
1
-77%
14
+1 179%
16
+20%
8
-54%
5
-38%
7
+49%
3
-64%
2
-1%
2
-19%
(0)
N/A
(0)
-2 600%
(5)
-18 670%
(5)
+0%
(10)
-96%
5
N/A
15
+205%
Financing Cash Flow
Net Issuance of Common Stock
2
0
1
3
2
0
18
18
0
0
39
39
0
0
0
0
0
0
0
0
0
0
0
0
13
13
21
22
0
13
Net Issuance of Debt
0
0
1
1
(0)
0
(1)
(1)
0
0
0
0
0
0
0
0
0
0
0
0
0
0
(0)
(0)
(0)
(0)
(0)
1
1
(0)
Other
0
0
0
0
0
0
(0)
(0)
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Cash from Financing Activities
2
N/A
0
N/A
2
N/A
4
+118%
2
-44%
0
-97%
16
+20 238%
16
+1%
0
-99%
0
-83%
39
+194 950%
39
+0%
0
-100%
0
-23%
0
-48%
0
-70%
0
-17%
0
+30%
0
-54%
0
+100%
0
N/A
0
-8%
(0)
N/A
(0)
-192%
13
N/A
13
-4%
21
+67%
22
+6%
1
-97%
13
+1 807%
Change in Cash
Net Change in Cash
(0)
N/A
(2)
-772%
0
N/A
2
+974%
0
-82%
(2)
N/A
7
N/A
5
-30%
(4)
N/A
(2)
+48%
(1)
+36%
3
N/A
5
+75%
(5)
N/A
(6)
-15%
5
N/A
7
+59%
(2)
N/A
(2)
-32%
3
N/A
(2)
N/A
(1)
+48%
(0)
+64%
(2)
-380%
10
N/A
4
-58%
12
+176%
5
-60%
(4)
N/A
20
N/A
Free Cash Flow
Free Cash Flow
(3)
N/A
(2)
+40%
(2)
-9%
(2)
N/A
(2)
-6%
(2)
-9%
(3)
-39%
(4)
-23%
(4)
-12%
(4)
-12%
(6)
-26%
(6)
-6%
(9)
-54%
(10)
-11%
(7)
+29%
(9)
-31%
(9)
-1%
(10)
-2%
(7)
+24%
(4)
+39%
(5)
-9%
(4)
+23%
(2)
+35%
(2)
+16%
(3)
-62%
(3)
-4%
(5)
-34%
(9)
-90%
(11)
-20%
(8)
+22%

See Also

Summary
ETX intrinsic value, competitors valuation, and company profile.
DCF Valuation
ETX stock valuation using Discount Cash Flow valuation method.
Relative Valuation
ETX stock valuation using valuation multiples.
Wall Street Estimates
ETX price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
ETX stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Follow us
Join more than 323,300+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.

AI Assistant
Get AI-powered insights for any company or topic.
Open AI Assistant
Other Tools
Stock Screener
Discover stocks
Stock Comparison
Smarter decisions through side-by-side analysis
Intrinsic Value Calculator
Discover the true worth of your stocks
DCF Value Calculator
Harness the power of DCF

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett